Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent <i>in vitro</i> and <i>in vivo</i> anticancer activity, characteristic of high tissue distribution
Jin‐Xue He(Shanghai Institute of Materia Medica), Ze‐Hong Miao(Shanghai Institute of Materia Medica)
Cited by 41
Related Papers
Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition
|Oncotarget|2015|52
Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells
|Acta Pharmacologica Sinica|2017|46
Tanshinone I inhibits tumor angiogenesis by reducing STAT3 phosphorylation at TYR705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells
|Oncotarget|2015|45
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
|EMBO Molecular Medicine|2023|42